- Home
- ABUS vs DLX Comparison
ABUS vs DLX Comparison
Compare ABUS & DLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- DLX
- Stock Information
- Founded
- ABUS 2005
- DLX 1915
- Country
- ABUS United States
- DLX United States
- Employees
- ABUS N/A
- DLX N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- DLX Advertising
- Sector
- ABUS Health Care
- DLX Consumer Discretionary
- Exchange
- ABUS Nasdaq
- DLX Nasdaq
- Market Cap
- ABUS 592.8M
- DLX 655.1M
- IPO Year
- ABUS N/A
- DLX N/A
- Fundamental
- Price
- ABUS $3.24
- DLX $14.83
- Analyst Decision
- ABUS Strong Buy
- DLX Strong Buy
- Analyst Count
- ABUS 4
- DLX 2
- Target Price
- ABUS $5.50
- DLX $31.00
- AVG Volume (30 Days)
- ABUS 1.3M
- DLX 363.1K
- Earning Date
- ABUS 05-05-2025
- DLX 04-30-2025
- Dividend Yield
- ABUS N/A
- DLX 8.06%
- EPS Growth
- ABUS N/A
- DLX 99.86
- EPS
- ABUS N/A
- DLX 1.18
- Revenue
- ABUS $6,171,000.00
- DLX $2,121,761,000.00
- Revenue This Year
- ABUS $14.57
- DLX $0.86
- Revenue Next Year
- ABUS $15.84
- DLX $1.12
- P/E Ratio
- ABUS N/A
- DLX $12.62
- Revenue Growth
- ABUS N/A
- DLX N/A
- 52 Week Low
- ABUS $2.63
- DLX $13.70
- 52 Week High
- ABUS $4.72
- DLX $24.87
- Technical
- Relative Strength Index (RSI)
- ABUS 50.09
- DLX 43.96
- Support Level
- ABUS $2.71
- DLX $14.01
- Resistance Level
- ABUS $3.32
- DLX $14.88
- Average True Range (ATR)
- ABUS 0.21
- DLX 0.76
- MACD
- ABUS 0.00
- DLX 0.07
- Stochastic Oscillator
- ABUS 63.86
- DLX 53.83
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About DLX Deluxe Corporation
Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.